<DOC>
	<DOC>NCT01271374</DOC>
	<brief_summary>The purpose of the study is to compare the effects of Azor (a combination of amlodipine and olmesartan) with Hyzaar ( a combination of losartan and hydrochlorothiazide) on the thin lining on the inside of blood vessels. These cells help keep blood vessels healthy and blood pressure normal.</brief_summary>
	<brief_title>Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome</brief_title>
	<detailed_description>Participants must be 18-75 years of age, African American, and have a combination of high blood pressure, insulin resistance (Type 2 Diabetes), low HDL cholesterol levels or obesity.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine Besylate, Olmesartan Medoxomil Drug Combination</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>African American Hypertension and one of the following: Fasting glucose &gt; 100 mg/dl HgA1C&gt; 6.0 % Plasma triglycerides &gt;150 HDL cholesterol &lt; 40 mg/dl in men or &lt; 50 mg/dl in women History of Heart failure use of insulin nondominant arm circ &gt; 50 cm.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>African American</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Cardiometabolic Syndrome</keyword>
</DOC>